Statins for secondary stroke prevention in patients without known coronary heart disease: The jury is still out

被引：9

作者：

Goldstein, LB

Amarenco, P

Bogousslavsky, J

Callahan, AS

Hennerici, MG

Welch, KMA

Zivin, J

Sillesen, H

机构：

[1] Duke Univ, Med Ctr, Durham, NC USA

[2] Hop Lariboisiere, F-75475 Paris, France

[3] CHU Lausanne, Lausanne, Switzerland

[4] Neurol Consultants PC, Nashville, TN USA

[5] Heidelberg Univ, Klinikum Mannheim, Mannheim, Germany

[6] Finch Univ Hlth Sci Chicago Med Sch, Chicago, IL USA

[7] Univ Calif San Diego, San Diego, CA 92103 USA

[8] Gentofte Univ Hosp, Hellerup, Denmark

来源：

CEREBROVASCULAR DISEASES | 2004年 / 18卷 / 01期

关键词：

D O I：

10.1159/000078600

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1 / 2

页数：2

共 8 条

[1] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[2]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[3]

PEDERSEN TR, 1994, LANCET, V344, P1383

[4] Reduction of stroke incidence after myocardial infarction with pravastatin -: The cholesterol and recurrent events (CARE) study [J].

Plehn, JF ;

Davis, BR ;

Sacks, FM ;

Rouleau, JL ;

Pfeffer, MA ;

Bernstein, V ;

Cuddy, TE ;

Moyé, LA ;

Piller, LB ;

Rutherford, J ;

Simpson, LM ;

Braunwald, E .

CIRCULATION, 1999, 99 (02) :216-223

[5] Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial [J].

Sever, PS ;

Dahlöf, B ;

Poulter, NR ;

Wedel, H ;

Beevers, G ;

Caulfield, M ;

Collins, R ;

Kjeldsen, SE ;

Kristinsson, A ;

McInnes, GT ;

Mehlsen, J ;

Nieminen, M ;

O'Brien, E ;

Östergren, J .

LANCET, 2003, 361 (9364) :1149-1158

[6] Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial [J].

Shepherd, J ;

Blauw, GJ ;

Murphy, MB ;

Bollen, ELEM ;

Buckley, BM ;

Cobbe, SM ;

Ford, I ;

Gaw, A ;

Hyland, M ;

Jukema, JW ;

Kamper, AM ;

Macfarlane, PW ;

Meinders, AE ;

Norrie, J ;

Packard, CJ ;

Perry, IJ ;

Stott, DJ ;

Sweeney, BJ ;

Twomey, C ;

Westendorp, RGJ .

LANCET, 2002, 360 (9346) :1623-1630

[7] Design and baseline characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study [J].

Sillesen, H .

CEREBROVASCULAR DISEASES, 2003, 16 (04) :389-395

[8]

Tonkin A, 1998, NEW ENGL J MED, V339, P1349

← 1 →